View Older Stories View More Recent Stories

Oct 2, 2018 01:00AM Genentech to Present Five-Year OCREVUS (Ocrelizumab) Efficacy and Safety Data in Relapsing and Primary Progressive Multiple Sclerosis at ECTRIMS
Sep 26, 2018 07:00PM Chugai and Lilly Enter into a License Agreement for Oral GLP-1 Agonist, OWL833
Sep 24, 2018 09:46AM Genentech's (RHHBY) Entrectinib Showes Durable Response of More Than Two Years in People With a Specific Type of Lung Cancer
Sep 24, 2018 09:45AM Genentech’s Investigational Medicine Entrectinib Showed a Durable Response of More Than Two Years in People With a Specific Type of Lung Cancer
Sep 6, 2018 01:00AM Genentech to Present New Data from Its Extensive Lung Cancer Program at the 2018 World Conference on Lung Cancer (WCLC)
Aug 6, 2018 12:00PM Foundation Medicine Publishes New Data in Nature Medicine Supporting Blood Tumor Mutational Burden (bTMB) as a Novel Predictor of Response to Cancer Immunotherapy
Jul 20, 2018 01:00AM Genentech to Present New Data Demonstrating the Breadth and Depth of Its Alzheimer’s Program at the Upcoming Alzheimer's Association International Conference (AAIC)
Jul 18, 2018 04:00PM Foundation Medicine (FMI), Guardant Health Agree to Settle Patent Infringement Lawsuit
Jul 18, 2018 04:00PM Foundation Medicine and Guardant Health Agree to Settle Patent Infringement Lawsuit
Jun 19, 2018 06:18AM Roche to Acquire Foundation Medicine (FMI) for $137/Share, or $5.3B
Jun 14, 2018 01:00AM Genentech Announces New OCREVUS (Ocrelizumab) Data on Long-Term Disability Benefits in Primary Progressive Multiple Sclerosis and Initiation of Two Global Studies in Progressive MS
Jun 5, 2018 07:00AM Foundation Medicine to Present at Upcoming Investor Conferences
May 29, 2018 07:00AM Foundation Medicine and Collaborators to Present New Data at ASCO 2018 Supporting Comprehensive Genomic Profiling (CGP) to Inform Personalized Approaches in Cancer Care
May 24, 2018 07:05AM Foundation Medicine (FMI) Reports Immuno-Oncology Companion Diagnostics Collaboration with Merck (MRK)
May 24, 2018 07:00AM Foundation Medicine Establishes Immuno-Oncology Companion Diagnostics Collaboration with Merck
May 21, 2018 07:00AM Foundation Medicine Receives New ADLT Status for FoundationOne CDx™ from the Centers for Medicare and Medicaid Services (CMS)
May 14, 2018 01:00AM Genentech to Present New Phase III Data for HEMLIBRA (emicizumab-kxwh) in People With Hemophilia A at the World Federation of Hemophilia 2018 World Congress
May 8, 2018 01:00AM Genentech to Present New Data from its Industry-Leading Oncology Portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
May 2, 2018 04:01PM Foundation Medicine Announces 2018 First Quarter Results and Recent Highlights
May 2, 2018 07:00AM Foundation Medicine Launches Gene Expression Profiling Program to Identify Known and Novel Biomarkers in Advanced Cancer
Apr 26, 2018 06:00PM Foundation Medicine, Roche and DIAN Diagnostics Collaborate to Advance Personalized Cancer Care in China
Apr 26, 2018 07:25AM Foundation Medicine (FMI) Says New Liquid Biopsy Assay Granted Breakthrough Device Designation
Apr 26, 2018 07:00AM Foundation Medicine’s New Liquid Biopsy Assay Granted Breakthrough Device Designation by U.S. Food and Drug Administration
Apr 23, 2018 01:00AM New OCREVUS (Ocrelizumab) Data at AAN Demonstrate Significant Reductions in Disease Activity and Disability Progression in Relapsing Multiple Sclerosis
Apr 17, 2018 07:00AM Foundation Medicine Announces Timing for First Quarter 2018 Financial Results and Conference Call
Apr 16, 2018 01:00AM Genentech to Present New Data at AAN Highlighting Extensive Research for OCREVUS and Expanding Neuroscience Pipeline
Apr 11, 2018 07:03AM Foundation Medicine (FMI), Collaborators Present New Findings Supporting Tissue- and Blood-based Comprehensive Genomic Profiling
Apr 11, 2018 07:00AM Foundation Medicine and its Collaborators Present New Findings Supporting Tissue- and Blood-based Comprehensive Genomic Profiling (CGP) to Inform Targeted and Cancer Immunotherapy Treatment Strategies
Apr 9, 2018 08:54AM Cancer Treatment Centers of America and Foundation Medicine Launch Joint Educational Campaign to Raise Consumer Awareness of Precision Medicine Approaches in Cancer Care
Mar 30, 2018 07:00AM Foundation Medicine Announces Commercial Availability of FoundationOne CDx™, the First FDA-Approved Comprehensive Genomic Profiling Assay for All Solid Tumors Incorporating Multiple Companion Diagno
Mar 18, 2018 10:19PM Foundation Medicine Announces Final National Coverage Determination (NCD) from the Centers for Medicare & Medicaid Services (CMS), Including Coverage for FoundationOne CDx™ Across All Solid Tumo
Mar 16, 2018 02:00AM Foundation Medicine Advances Patient Access to Precision Medicine; Pursues Regulatory Approval for FoundationOne CDx™ in Japan
Mar 13, 2018 04:05PM Foundation Medicine and Guardant Health Agree to Resolve False Advertising Lawsuit
Mar 8, 2018 06:30AM Foundation Medicine to Present at Cowen and Company’s 38th Annual Healthcare Conference
Mar 7, 2018 04:01PM Foundation Medicine Announces 2017 Fourth Quarter and Year-End Results, Recent Highlights and 2018 Outlook
Feb 13, 2018 06:30AM Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2017 Financial Results and Conference Call
Feb 5, 2018 06:59AM Pivotal Phase 3 CheckMate -227 Study Demonstrates Superior Progression-Free Survival (PFS) with the Opdivo Plus Yervoy Combination Versus Chemotherapy in First-Line Non-Small Cell Lung Cancer (NSCLC)
Jan 30, 2018 07:00AM Foundation Medicine and European Organisation for Research and Treatment of Cancer (EORTC) Announce Collaboration to Advance Precision Medicine Using Comprehensive Genomic Profiling to Facilitate Clin
Jan 16, 2018 07:05AM Foundation Medicine (FMI), Pfizer (PFE) Announce Pact to Develop Companion Diagnostics for Pfizer's Oncology Portfolio
Jan 16, 2018 07:00AM Foundation Medicine and Pfizer Announce Broad Partnership to Develop Companion Diagnostics for Pfizer’s Oncology Portfolio
Jan 8, 2018 06:34AM Foundation Medicine (FMI) Prelim. Q4 Revenue Tops Views
Jan 8, 2018 06:30AM Foundation Medicine Reports Preliminary 2017 Results
Jan 8, 2018 01:00AM GE, Roche Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment
Jan 3, 2018 04:01PM Foundation Medicine to Present at the 36th Annual J.P. Morgan Healthcare Conference
Dec 6, 2017 07:00AM Foundation Medicine and Collaborators to Present New Data at the American Society of Hematology (ASH) Annual Meeting that Supports Use of FoundationOne®Heme to Advance Personalized Medicine in Blood
Nov 30, 2017 11:15PM FDA Approves Foundation Medicine’s FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics
Nov 1, 2017 04:01PM Foundation Medicine Announces 2017 Third Quarter Results and Recent Highlights
Nov 1, 2017 12:30PM Genentech to Present New Data Across a Range of Blood Diseases at the American Society of Hematology (ASH) 2017 Annual Meeting
Oct 27, 2017 01:00AM New OCREVUS (Ocrelizumab) Data at ECTRIMS Advance Clinical Understanding of Underlying Progression in Multiple Sclerosis
Oct 16, 2017 07:00AM Foundation Medicine to Present Validation for FoundationOne CDx™, a Comprehensive Genomic Profiling Assay for Advancing Precision Cancer Care
View More Recent Stories View Older Stories